Korean J Gastroenterol.
2000 Jan;35(1):93-102.
Diagnostic Utility of K-ras Mutation in the Sample of Percutaneous Needle Aspiraton of Pancreatic Cancer and Chronic Pancreatitis
Abstract
- BACKGROUND/AIMS
K-ras gene mutation is present in 80-90% of human pancreatic cancer and thus, could be used as a new diagnostic tool. The purpose of this study was to assess the utility of K-ras mutation analysis in the differential diagnosis of pancreatic diseases using the percutaneous needle aspirates of pancreatic masses. METHODS: Aspirates of 16 patients with pancreatic cancer, 4 patients with chronic pancreatitis and 4 patients with pancreatic cysts were collected prospectively. Cytological analysis was performed and DNA was extracted simultaneously from the samples. K-ras mutations were detected by the enriched polymerase chain reaction-restriction fragment length polymorphism method and the DNA sequence was analyzed. RESULTS: K-ras mutations were detected in 9 (56%) of 16 cases of pancreatic cancer. Cytological analysis for the patients with pancreatic cancer revealed malignant tumors in nine patients, atypia in two, and benign tumors in five. In combination with cytological analysis, detection of K-ras mutations offered a diagnostic sensitivty of 81%. The most frequently observed mutation was G-A transitions (GGT-GAT) at codon 12, resulting in alteration of Glycine to Aspartic acid. However, 1 of 4 patients with chronic pancreatitis and 2 of 4 patients with pancreatic cysts also showed K-ras mutation. CONCLUSIONS: Although the detection of K-ras mutation from the percutaneous needle aspirates can enhance the sensitivity for the diagnosis of pancreatic cancer, its clinical use is limited because of the nonspecificity.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Telomerase Activity and K-ras Gene Mutation in Pancreatic Juice for Diagnosis of Pancreatic Cancer
- Detection of Point Mutations in the K-ras Oncogene in Pancreatic Juice for Differential Diagnosis between Pancreatic Carcinoma and Chronic Pancreatitis
- Clinical Significance of p53 Protein Expression and K-ras Point Mutation in Pancreatic Cancer and Chronic Pancreatitis
- Detection of Point Mutations in the K-ras Oncogene in Pancreatic Juice for Diagnosis of Pancreatic Carcinoma
- Clinical Utility of Fecal Elastase 1 Test in Chronic Pancreatitis
